Free Trial

CG Oncology (CGON) SEC Filings & 10K Form

CG Oncology logo
$30.94 +2.27 (+7.92%)
Closing price 04:00 PM Eastern
Extended Trading
$30.92 -0.02 (-0.05%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent CG Oncology SEC Filings

DateFilerForm TypeView
09/03/2025
3:29 PM
CG Oncology (Subject)
POST LEONARD E (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/08/2025
3:15 PM
CG Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2025
7:15 AM
CG Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2025
3:30 PM
CG Oncology (Issuer)
POST LEONARD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2025
3:22 PM
CG Oncology (Subject)
POST LEONARD E (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2025
3:15 PM
CG Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
7:30 AM
CG Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2025
7:15 AM
CG Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
3:15 PM
CG Oncology (Issuer)
POST LEONARD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
6:30 AM
CG Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2025
7:05 AM
CG Oncology (Filer)
Form DEF 14A
04/25/2025
7:09 AM
CG Oncology (Filer)
Form DEFA14A
04/25/2025
7:13 AM
CG Oncology (Filer)
Form ARS
03/28/2025
3:57 PM
CG Oncology (Filer)
Form S-3ASR
03/28/2025
7:59 AM
CG Oncology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2025
6:15 AM
CG Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
7:30 AM
CG Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
3:30 PM
CG Oncology (Issuer)
POST LEONARD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
3:38 PM
CG Oncology (Subject)
POST LEONARD E (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
4:40 PM
CG Oncology (Subject)
Decheng Capital Global Life Sciences Fund IV, L.P. (Filed by)
Form SCHEDULE 13G/A
01/14/2025
3:16 PM
CG Oncology (Issuer)
POST LEONARD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
5:03 PM
CG Oncology (Issuer)
Song Hong Fang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
11:15 PM
CG Oncology (Filer)
Form EFFECT
12/11/2024
3:09 PM
CG Oncology (Filer)
Form S-1/A
12/11/2024
5:06 AM
CG Oncology (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/06/2024
5:51 PM
CG Oncology (Issuer)
POST LEONARD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
6:52 AM
CG Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
1:30 PM
CG Oncology (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
9:22 AM
CG Oncology (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
CG Oncology (Subject)
Form SC 13G
10/08/2024
8:29 AM
CG Oncology (Issuer)
Roche Corleen M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
4:17 PM
CG Oncology (Issuer)
POST LEONARD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
3:51 PM
CG Oncology (Issuer)
Kuan Arthur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
3:56 PM
CG Oncology (Issuer)
Patterson Joshua F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
4:00 PM
Bellete Ambaw (Reporting)
CG Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
4:00 PM
CG Oncology (Issuer)
Mulay James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
4:03 PM
CG Oncology (Issuer)
Song Hong Fang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
4:07 PM
CG Oncology (Issuer)
Kasturi Vijay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
4:07 PM
CG Oncology (Issuer)
Tong Victor Edward Jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
4:08 PM
CG Oncology (Issuer)
Liu Brian Guan-Chyun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
4:09 PM
CG Oncology (Issuer)
Graf Susan E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CGON) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners